Elevated serum amyloid A levels are associated with rapidly progressive interstitial lung disease in dermatomyositis: A retrospective cohort study.
文献摘要
Background Prompt identification of rapidly progressive interstitial lung disease (RP-ILD) in dermatomyositis (DM) is crucial; however, reliable biomarkers remain lacking. Objectives To evaluate the association between serum amyloid A (SAA) and RP-ILD in DM. Methods SAA levels were quantified via scattering turbidimetry. Spearman's correlation analyzed associations with serologic markers. Diagnostic thresholds were determined through Receiver operating characteristic curve analysis, and independent markers associated with mortality were identified using Cox proportional hazards models. Results SAA levels were significantly higher in patients with DM than in healthy controls (37.71 ± 6.93 vs 5.42 ± 0.30 mg/L; P 21.98 mg/L had significantly worse survival (P 21.98 mg/L independently implied mortality in multivariable analysis (HR = 14.12; 95% CI: 1.16-171.33; P = .038). Limitations This was a retrospective, single-center cohort with a modest sample size. Conclusion Elevated SAA is associated with increased frequency of RP-ILD and mortality. Combining SAA with anti-MDA5 antibody optimizes risk stratification and concurrent disease severity evaluation.